You Position: Home > Paper
New hot spots on biomarkers for non-small cell lung cancer
( views:315, downloads:90 )
- Author:
- No author available
- Journal Title:
- CANCER RESEARCH AND CLINIC
- Issue:
- 9
- DOI:
- 10.3760/cma.j.issn.1006-9801.2010.09.005
- Key Word:
- 癌,非小细胞肺;生物学标记;Carcinoma,non-small-cell lung;Biomarker
Abstract： As a hot topic, biomarkers can provide reliable evidence for the individualized treatment of non-small cell lung cancer. With the further study of molecular biology and development of new drugs,biomarkers have shown a broad prospect in clinical application. Combining with the research in recent years,this review describes the progress in biomarkers for non-small-cell lung cancer.
- [1]Fukuoka J,Tsurutani J,Dennis PA,etc.Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors.[J].2006,24(2).
- [2]Horn L,Pao W.EML4-ALK: honing in on a new target in non-small-cell lung cancer.[J].2009,27(26).
- [3]Kohno S,Ballas M,Soda H,etc.Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma.[J].2007,55(1).
- [4]Shaw AT,Mino Kenudson M,Yeap BY.Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.[J].2009,27(26).
- [5]Yildiz P,Shyr Y,Rahman SM,etc.Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.[J].2004,170(10).
- [6]Zucali PA,Ruiz MG,Giovannetti E,etc.Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.[J].2008,19(9).